(Q64449315)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16806598%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

title

Multivalent DNA vaccine protects mice against pulmonary infection caused by Pseudomonas aeruginosa (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16806598%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

main subject

Pseudomonas aeruginosa

1 reference

Sukumar Saha

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16806598%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Fumihiko Takeshita

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16806598%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Shin Sasaki

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16806598%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Tomoko Matsuda

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16806598%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Toshiyuki Tanaka

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16806598%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Miyuki Tozuka

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16806598%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Keiko Takase

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16806598%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Tetsuya Matsumoto

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16806598%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Katsuji Okuda

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16806598%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Norihisa Ishii

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16806598%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Keizo Yamaguchi

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16806598%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Dennis M Klinman

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16806598%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Ke-Qin Xin

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16806598%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Kenji Okuda

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16806598%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

language of work or name

English

0 references

publication date

9 June 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16806598%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16806598%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

volume

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16806598%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

issue

37-39

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16806598%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

page(s)

6240-6249

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16806598%20AND%20SRC:MED&resulttype=core&format=json

CFTR mutations and host susceptibility to Pseudomonas aeruginosa lung infection.

26 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.077

Prophylaxis and therapy of Pseudomonas aeruginosa infection in cystic fibrosis and immunocompromised patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.077

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.077

Protective effect of DNA vaccine during chemotherapy on reactivation and reinfection of Mycobacterium tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.077

Transplacental genetic immunization after intravenous delivery of plasmid DNA to pregnant mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.077

Apoptosis-mediated enhancement of DNA-raised immune responses by mutant caspases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.077

Combination of DNA vaccine and adenovirus vector by cutaneous administration induced strong HIV-specific cellular immune responses in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.077

Differential immunogenicity of various heterologous prime-boost vaccine regimens using DNA and viral vectors in healthy volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.077

The regulation of DNA vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.077

DNA vaccines against chronic lung infections by Pseudomonas aeruginosa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.077

Utilization of genomic sequence information to develop malaria vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.077

The immunogenicity of single and combination DNA vaccines against tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.077

Immunogenicity of Multiple Gene and Clade Human Immunodeficiency Virus Type 1 DNA Vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.077

Dual-function vaccine for Pseudomonas aeruginosa: characterization of chimeric exotoxin A-pilin protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.077

Effect of passive immunotherapy on murine gut-derived sepsis caused by Pseudomonas aeruginosa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.077

Structural gene and complete amino acid sequence of Pseudomonas aeruginosa IFO 3455 elastase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.077

Safety and immunogenicity of an intranasal Pseudomonas aeruginosa hybrid outer membrane protein F-I vaccine in human volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.077

Immunomodulation by apoptosis-inducing caspases for an influenza DNA vaccine delivered by gene gun.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.077

Transcriptional regulation of the human TLR9 gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.077

CXC chemokine receptor CXCR2 is essential for protective innate host response in murine Pseudomonas aeruginosa pneumonia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.077

Cloning and expression of the alkaline proteinase gene from Pseudomonas aeruginosa IFO 3455.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.077

Efficacies of alkaline protease, elastase and exotoxin A toxoid vaccines against gut-derived Pseudomonas aeruginosa sepsis in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.077

Promises and pitfalls of Pseudomonas aeruginosa lipopolysaccharide as a vaccine antigen.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.077

Detection of elastase production in Escherichia coli with the elastase structural gene from several non-elastase-producing strains of Pseudomonas aeruginosa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.077

Pseudomonas immunotherapy: a historical overview

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.077

Protection against P. aeruginosa with an adenovirus vector containing an OprF epitope in the capsid.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.077

Active and passive immunization with the Pseudomonas V antigen protects against type III intoxication and lung injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.077

Therapeutic administration of anti-PcrV F(ab')(2) in sepsis associated with Pseudomonas aeruginosa.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.077

Reduced immunogenicity of DNA vaccine plasmids in mixtures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.077

Increased DNA vaccine delivery and immunogenicity by electroporation in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.077

Macrophages RestrictPseudomonas aeruginosaGrowth, Regulate Polymorphonuclear Neutrophil Influx, and Balance Pro- and Anti-Inflammatory Cytokines in BALB/c Mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.077

Defective Phagocytosis and Clearance of Pseudomonas aeruginosa in the Lung Following Bone Marrow Transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.077

Antibody isotype-specific engagement of Fcgamma receptors regulates B lymphocyte depletion during CD20 immunotherapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.077

Enhancement of the protective efficacy of an oprF DNA vaccine against Pseudomonas aeruginosa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.077

Role of Pseudomonas aeruginosa pili in acute pulmonary infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.077

Site-directed mutagenesis of Glu-141 and His-223 in Pseudomonas aeruginosa elastase: catalytic activity, processing, and protective activity of the elastase against Pseudomonas infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.077

inferred from DOI database lookup

7 January 2021

based on heuristic

Alteration of the pilin adhesin of Pseudomonas aeruginosa PAO results in normal pilus biogenesis but a loss of adherence to human pneumocyte cells and decreased virulence in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.077

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2006.05.077

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16806598%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

1 reference